Blogs

Learn with Maqro

Knowledge is power. So to support our powerful investing platform, Maqro provides a library of different topics and ideas to assist you on your investing journey. Explore our articles and blogs that are diligently created from our internal research division to further your knowledge into the stockmarket.
blog-hero-image

Discover categories you’re interested in

The line between tactical investments and risky bets

Stocks

The line between tactical investments and risky bets

SoftBank sells Arm for Stake in NvidiaSoftBank announced it would be swapping its $40 bn ownership in Arm, for a $21 bn stake in software company Nvidia. This is possibly the priciest semiconductor sale seeing...

Cameron Gupta

Reporting Season: Afterpay Limited (APT.ASX)

Stocks

Reporting Season: Afterpay Limited (APT.ASX)

Maqro Adviser Video Commentary Maqro Research Team CoverageOverall, APT’s earnings beat market expectations, with its revenue and EPS ahead of estimates, largely due to a lower provision from higher than anticipated collections of instalment payments during...

Edward Heng

Edward Heng

Reporting Season: Mesoblast Ltd (MSB.ASX)

Stocks

Reporting Season: Mesoblast Ltd (MSB.ASX)

Maqro Research Team CoverageOverall strong performance, with 92% increase in revenues and 13% reduction in loss after tax despite increased investment in commercial readiness for the potential launch of RYONCIL in the US.Key event in...

Edward Heng

Edward Heng

Reporting Season: Regis Resources Ltd (RRL.ASX)

Stocks

Reporting Season: Regis Resources Ltd (RRL.ASX)

Maqro Research Team CoverageOverall, RRL missed expectations on both earnings and dividend, although growing significantly from last year. This is largely due to a much higher average realised price of gold as RRL’s production numbers...

Edward Heng

Edward Heng

Reporting Season: Nanosonics Ltd (NAN.ASX)

Stocks

Reporting Season: Nanosonics Ltd (NAN.ASX)

Overall, NAN missed expectations, with the weakness in earnings attributed to a low Q4 growth (driven by reduction in range of healthcare procedures and limited hospital access due to COVID-19).R&D expenses also significantly increased (by...

Edward Heng

Edward Heng

Reporting Season: Sandfire Resources Ltd (SFR.ASX)

Stocks

Reporting Season: Sandfire Resources Ltd (SFR.ASX)

Maqro Research Team CoverageOverall, SFR’s results were broadly in-line with expectations, with a downgrade to FY21’s production already known beforehand from its Q4 report released a month ago. The key highlight is the higher than...

Aditya Kapdi

The Race to Develop a Vaccine

Investing Psychology

The Race to Develop a Vaccine

Before a vaccine can reach the human trials stage, there are several prior phases that must be approved. Phase 1 involves safety tests to control the correct dosage amount, side effects that exist and confirmation...

Jay Swami

Jay Swami

The Race to Develop a Vaccine: Who’s Winning?

Investing Psychology

The Race to Develop a Vaccine: Who’s Winning?

Before a vaccine can reach the human trials stage, there are several prior phases that must be approved. Phase 1 involves safety tests to control the correct dosage amount, side effects that exist and...

Jay Swami

Reporting Season: Fortescue Metals Group Ltd (FMG.ASX)

Stocks

Reporting Season: Fortescue Metals Group Ltd (FMG.ASX)

Overall, FMG beat expectations, with its dividend being the highlight of the report (significantly higher than expectations, with a payout ratio of 77%). Its outlook is neutral/slightly bearish, with production numbers not expected to change...

Edward Heng

Edward Heng

Ready to invest with Maqro today?

Sign up to Maqro